SCHEMBL24773576

SCHEMBL24773576

C=CC(=O)Nc1ccc(-c2c(C#N)cnc(N)c2-c2ccc(Oc3nccc(C)n3)c(F)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 2/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ FGFR1 P11362 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ FGFR2 P21802 1/20 0.49
▸ FGFR3 P22607 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ EGFR P00533 11/20 0.40
▸ BTK Q06187 4/20 0.40
▸ ALOX5AP P20292 3/20 0.38
▸ FEN1 P39748 3/20 0.38
▸ TBK1 Q9UHD2 1/20 0.38
▸ ITK Q08881 4/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ MET P08581 1/20 0.34
▸ FLT3 P36888 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31213925 0.86 FGFR4 (0.60) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24773340 0.85 FGFR4 (0.56) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24773303 0.83 FGFR4 (0.58) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24772736 0.82 FGFR4 (0.57) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24772743 0.82 FGFR4 (0.51) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24772733 0.81 FGFR1 (0.51) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24772744 0.81 FGFR4 (0.49) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24773565 0.80 FGFR4 (0.49) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL24772972 0.79 FGFR4 (0.53) FGFR4CYP3A4CYP2D6FGFR1CYP2C9
SCHEMBL30325892 0.78 FGFR4 (0.41) FGFR4CYP3A4CYP2D6FGFR1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022206939-A1 HETEROCYCLIC COMPOUND SERVING AS FGFR INHIBITOR AND APPLICATION THEREOF 海南耀臻生物医药科技有限公司 2022-10-06 — — WO disclosed
Send feedback